These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 12617973)

  • 1. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.
    Lorrain DS; Baccei CS; Bristow LJ; Anderson JJ; Varney MA
    Neuroscience; 2003; 117(3):697-706. PubMed ID: 12617973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge.
    Fell MJ; Katner JS; Johnson BG; Khilevich A; Schkeryantz JM; Perry KW; Svensson KA
    Neuropharmacology; 2010 Mar; 58(3):632-9. PubMed ID: 19951716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat.
    Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
    J Neurochem; 2000 Sep; 75(3):1147-54. PubMed ID: 10936197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
    Lorrain DS; Schaffhauser H; Campbell UC; Baccei CS; Correa LD; Rowe B; Rodriguez DE; Anderson JJ; Varney MA; Pinkerton AB; Vernier JM; Bristow LJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1622-32. PubMed ID: 12825094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade.
    Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
    Neuropharmacology; 2001 Jun; 40(7):847-55. PubMed ID: 11378155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of NMDA receptors in regulating group II metabotropic glutamate receptor-mediated long-term depression in rat medial prefrontal cortex.
    Huang CC; Hsu KS
    Neuropharmacology; 2008 Jun; 54(7):1071-8. PubMed ID: 18378263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex.
    Swanson CJ; Perry KW; Schoepp DD
    J Neurochem; 2004 Jan; 88(1):194-202. PubMed ID: 14675163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
    Pitsikas N; Markou A
    Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention deficit induced by blockade of N-methyl D-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: role of metabotropic glutamate receptors 2/3.
    Pozzi L; Baviera M; Sacchetti G; Calcagno E; Balducci C; Invernizzi RW; Carli M
    Neuroscience; 2011 Mar; 176():336-48. PubMed ID: 21193020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum.
    Cartmell J; Salhoff CR; Perry KW; Monn JA; Schoepp DD
    Brain Res; 2000 Dec; 887(2):378-84. PubMed ID: 11134627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex.
    Kiritoshi T; Neugebauer V
    Neuropharmacology; 2015 Aug; 95():388-94. PubMed ID: 25912637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
    Fell MJ; Perry KW; Falcone JF; Johnson BG; Barth VN; Rash KS; Lucaites VL; Threlkeld PG; Monn JA; McKinzie DL; Marek GJ; Svensson KA; Nelson DL
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1126-36. PubMed ID: 19755662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat.
    Imre G; Salomons A; Jongsma M; Fokkema DS; Den Boer JA; Ter Horst GJ
    Pharmacol Biochem Behav; 2006 Jul; 84(3):392-9. PubMed ID: 16857251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of dendritic release of dopamine by metabotropic glutamate receptors in rat substantia nigra.
    Campusano JM; Abarca J; Forray MI; Gysling K; Bustos G
    Biochem Pharmacol; 2002 Apr; 63(7):1343-52. PubMed ID: 11960611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.
    Okamura N; Hashimoto K; Shimizu E; Koike K; Ohgake S; Koizumi H; Kumakiri C; Komatsu N; Iyo M
    Brain Res; 2003 Nov; 992(1):114-9. PubMed ID: 14604779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell.
    Greenslade RG; Mitchell SN
    Neuropharmacology; 2004 Jul; 47(1):1-8. PubMed ID: 15165829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptors in the prefrontal cortex regulate dopamine efflux to stress via descending glutamatergic feedback to the ventral tegmental area.
    Butts KA; Phillips AG
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1799-807. PubMed ID: 23590841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex.
    Yonezawa Y; Kuroki T; Kawahara T; Tashiro N; Uchimura H
    Eur J Pharmacol; 1998 Jan; 341(1):45-56. PubMed ID: 9489855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands.
    Smolders I; Lindekens H; Clinckers R; Meurs A; O'Neill MJ; Lodge D; Ebinger G; Michotte Y
    J Neurochem; 2004 Mar; 88(5):1068-77. PubMed ID: 15009663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.